Objective: Excessive weight gain has been reported with integrase strand transfer inhibitors
(INSTIs). We evaluated weight changes in virologically suppressed adults with HIV who …

Introduction: Randomized trials of new agents for HIV pre-exposure prophylaxis (PrEP) compare
against emtricitabine and tenofovir disoproxil fumarate (F/TDF), without a placebo group…

Trials of candidate agents for HIV pre-exposure prophylaxis (PrEP) might randomly assign
participants to be given a new PrEP agent or oral coformulated tenofovir disoproxil fumarate …

Introduction: This study investigates patterns of intertwin size discordance in dichorionic
diamniotic (DCDA) and monochorionic diamniotic (MCDA) twin pregnancies. Material and …

Tenofovir disoproxil fumarate combined with emtricitabine is a highly effective oral pre-exposure
prophylaxis (PrEP) agent for preventing the acquisition of HIV. This effectiveness has …

Active-control trials, where an experimental treatment is compared with an established treatment,
are performed when the inclusion of a placebo control group is deemed to be unethical…

Longitudinal data are widely analysed using linear mixed models, with ‘random slopes’
models particularly common. However, when modelling, for example, longitudinal pre‐treatment …

… T L and T R , respectively, and denote the point in calender time of HIV infection in the i th
patient as t … patient can only be included in the cohort if T L <t i +τ i . The right truncation results …

Objectives The aim of this study was to investigate associations between baseline characteristics
and CD4 cell count response on first-line antiretroviral therapy and risk of virological …

Background There has been some debate in the literature as to whether baseline values of a
measurement of interest at treatment initiation should be treated as an outcome variable as …